Initial Therapy With the Fixed-Dose Combination (FDC) of Sitagliptin and Metformin (JANUMET (TM)) in Patients with Type 2 Diabetes Mellitus (T2DM) Provides Superior Glycemic Control and A1C Goal Attainment with Lower Rates of Abdominal Pain and Diarrhea vs. Metformin Alone

Charles A. Reasner,Leann Olansky, Thomas L. Seck, Debora E. Williams-Herman,Edmund Luo,Menghui Chen,Leah B. Reigle, Yan Ling, Amy O. Johnson-Levonas,Keith D. Kaufman,Barry J. Goldstein

DIABETES(2009)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要